Pages that link to "Q40088682"
Jump to navigation
Jump to search
The following pages link to Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification (Q40088682):
Displayed 50 items.
- The effect on cell growth by Wnt1 RNAi in human neuroblastoma SH-SY5Y cell line (Q24316290) (← links)
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway (Q24322825) (← links)
- Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors (Q27684215) (← links)
- Molecular pathogenesis of peripheral neuroblastic tumors (Q28271405) (← links)
- HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome (Q28652372) (← links)
- Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation (Q30974276) (← links)
- Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha (Q34420371) (← links)
- WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway (Q34456446) (← links)
- Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch (Q34460281) (← links)
- Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization (Q34885515) (← links)
- ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma (Q34891827) (← links)
- Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures (Q34916522) (← links)
- Characteristic Markers of the WNT Signaling Pathways Are Differentially Expressed in Osteoarthritic Cartilage. (Q34978205) (← links)
- Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers (Q35251049) (← links)
- Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk (Q35600613) (← links)
- Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma (Q35976974) (← links)
- Functional genomics identifies therapeutic targets for MYC-driven cancer (Q36066213) (← links)
- ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. (Q36435476) (← links)
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma (Q36893712) (← links)
- L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth (Q37078762) (← links)
- Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression (Q37225412) (← links)
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas (Q37384952) (← links)
- Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma (Q37605450) (← links)
- Apoptotic cell death in neuroblastoma (Q37679253) (← links)
- p53 family: Therapeutic targets in neuroblastoma (Q37707387) (← links)
- MYC in oncogenesis and as a target for cancer therapies (Q37732974) (← links)
- Children's Oncology Group's 2013 blueprint for research: neuroblastoma (Q38068818) (← links)
- LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma (Q38261762) (← links)
- Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis. (Q38504083) (← links)
- Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. (Q38702196) (← links)
- TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation (Q38896647) (← links)
- RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma (Q39225715) (← links)
- Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. (Q39583166) (← links)
- Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways (Q40854205) (← links)
- Wnt signalling is a bi-directional vulnerability of cancer cells (Q42321100) (← links)
- p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance (Q42362115) (← links)
- Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer (Q44768409) (← links)
- N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells (Q46809713) (← links)
- WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma (Q47618158) (← links)
- Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma. (Q48355318) (← links)
- The expression of SFRP1, SFRP3, DVL1, and DVL2 proteins in testicular germ cell tumors. (Q51531942) (← links)
- Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma. (Q52673795) (← links)
- NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth. (Q53189212) (← links)
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations (Q55463889) (← links)
- Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma (Q59884668) (← links)
- Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4 (Q61136153) (← links)
- Wnt Signaling Is a Major Determinant of Neuroblastoma Cell Lineages (Q64108352) (← links)
- Neonatal tumours (Q86615686) (← links)
- A Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in Neuroblastoma (Q90632923) (← links)
- WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating (Q91560411) (← links)